Q2 Results: Sun Pharma Posts Surprise Loss Due To Anti-Litigation Provision
Tablets pass through a blister pack packaging machine inside a pharmaceutical laboratory. (Photographer: Martin Leissl/Bloomberg)

Q2 Results: Sun Pharma Posts Surprise Loss Due To Anti-Litigation Provision

Sun Pharmaceutical Industries Ltd. reported an unexpected loss for the quarter ended September due to a one-off anti-trust litigation provision.The company posted a net loss of Rs 219 crore against...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.